Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2015-11-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于部分董事监事换届离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's board of directors and supervisory board members following a shareholders' meeting. It details the departure of specific independent directors and a supervisory board chairman, their shareholdings, and compliance with relevant regulations. There is no financial data, earnings information, or report publication mentioned. The content fits the category of Board/Management Information, as it concerns changes in senior management and board members.
2015-11-25 Chinese
第三届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the first meeting of the third board of directors of 福安药业（集团）股份有限公司 held on November 25, 2015. It details the election of the chairman, appointment of various board committees, and appointments of senior management positions such as general manager, board secretary, financial director, deputy general managers, audit department head, and securities affairs representative. The document includes voting results and biographies of the appointed individuals. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes and appointments in the company's board and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is over 5,000 characters and contains substantive content about management changes, not just an announcement or certification, so it is not RPA or RNS. Confidence is high due to clear and detailed management appointment disclosures.
2015-11-25 Chinese
独立董事关于第三届董事会第一会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on the appointment of senior management at the company's third board meeting. It references regulatory guidelines and company bylaws but does not contain financial data or results. It is a governance-related announcement about board/management changes rather than a full management report or annual report. The document length is short and focused on management appointments, fitting the Board/Management Information category.
2015-11-25 Chinese
2015年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening and procedures of the 2015 third extraordinary general meeting of shareholders of a company. It details the legality of the meeting's notice, attendance, voting procedures, and resolutions passed. It does not contain financial statements or results but focuses on the legality and validity of the shareholder meeting and its resolutions. This type of document is typically associated with announcements or confirmations of shareholder meeting outcomes, specifically the voting results. Therefore, the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and is a legal opinion letter rather than the meeting materials themselves, so it is not AGM Information or Proxy Solicitation. Hence, the classification is DVA with high confidence.
2015-11-25 Chinese
2015年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2015 third extraordinary shareholders meeting of the company 福安药业. It details the meeting date, voting procedures, attendance, and the results of votes on various board and supervisory committee elections. It also includes a legal opinion confirming the legality and validity of the meeting and resolutions. The document is primarily focused on announcing the official voting results of the shareholders meeting, not the meeting materials or presentations themselves. The length is about 4206 characters, which is relatively short and consistent with a voting results announcement rather than a full report or presentation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2015-11-25 Chinese
第三届监事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolution passed at the first meeting of the third Supervisory Board of the company, including the election of the Supervisory Board Chairman. It contains no financial data, no report content, and no mention of financial results or regulatory filings beyond the meeting resolution. It is an announcement related to board/management changes, specifically the election of a board member (Supervisory Board Chairman). Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a report or financial disclosure.
2015-11-25 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.